-
1Academic Journal
المؤلفون: Ryota Shigaki, Ryohei Yoshida, Akari Yagita, Kazunori Nagasue, Taeka Naraoka, Kiichi Nitanai, Hiraku Yanada, Toshiyuki Tenma, Ryotaro Kida, Yasuhiro Umekage, Chie Mori, Yoshinori Minami, Hideki Sato, Kuninori Iwayama, Yasuhisa Hashino, Masahide Fukudo, Takaaki Sasaki
المصدر: Frontiers in Oncology, Vol 13 (2023)
مصطلحات موضوعية: blood level, Kirsten rat sarcoma viral oncogene homologue, patients, side effect, sotorasib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Yasuhisa Hashino, Kengo Umehara, Shinya Takada, Kuninori Iwayama, Koichi Ohtaki, Hideki Sato
المصدر: Journal of Biophysical Chemistry. 14:67-78
مصطلحات موضوعية: General Materials Science
-
3Academic Journal
المؤلفون: YASUHISA HASHINO, TAKUMU MATUSHITA, TAE HATSUYAMA, AZUSA WAKAMOTO, KEISUKE GOTO, TAKANOBU HOSHI, KUNINORI IWAYAMA, KOICHI OHTAKI, TAKAKI TODA, HIDEKI SATO
المصدر: In Vivo; Mar/Apr2024, Vol. 38 Issue 2, p864-872, 9p
مصطلحات موضوعية: DRUG side effects, LUNG cancer treatment, PEMBROLIZUMAB, NON-small-cell lung carcinoma, CANCER prognosis
-
4Image
المؤلفون: Ryota Shigaki, Ryohei Yoshida, Akari Yagita, Kazunori Nagasue, Taeka Naraoka, Kiichi Nitanai, Hiraku Yanada, Toshiyuki Tenma, Ryotaro Kida, Yasuhiro Umekage, Chie Mori, Yoshinori Minami, Hideki Sato, Kuninori Iwayama, Yasuhisa Hashino, Masahide Fukudo, Takaaki Sasaki
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, blood level, Kirsten rat sarcoma viral oncogene homologue, patients, side effect, sotorasib
-
5Academic Journal
المؤلفون: YASUHISA HASHINO, TAE HATSUYAMA, KUNINORI IWAYAMA, TAKANOBU HOSHI, AZUSA WAKAMOTO, KOICHI OHTAKI, TAKAKI TODA, HIDEKI SATO
المصدر: In Vivo; Nov/Dec2023, Vol. 37 Issue 6, p2669-2677, 8p
مصطلحات موضوعية: OSIMERTINIB, LUNG cancer, CANCER treatment, EPIDERMAL growth factor receptors, PROGRESSION-free survival